Circulating microRNA Testing for the Early Diagnosis and Follow-up of Colorectal Cancer Patients

[1]  Y. Toiyama,et al.  Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer , 2014, Annals of surgery.

[2]  O. Lingjaerde,et al.  Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first‐line oxaliplatin‐based treatment , 2014, Molecular oncology.

[3]  R. Biondi,et al.  Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers , 2013, PloS one.

[4]  S. Rai,et al.  A Plasma MicroRNA Panel for Detection of Colorectal Adenomas: A Step Toward More Precise Screening for Colorectal Cancer , 2013, Annals of surgery.

[5]  Y. Akao,et al.  Role of Intracellular and Extracellular MicroRNA-92a in Colorectal Cancer. , 2013, Translational oncology.

[6]  Irene Moya,et al.  microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers. , 2013, Oncology reports.

[7]  S. Juo,et al.  The Functional Significance of MicroRNA-29c in Patients with Colorectal Cancer: A Potential Circulating Biomarker for Predicting Early Relapse , 2013, PloS one.

[8]  Y. Toiyama,et al.  Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. , 2013, Journal of the National Cancer Institute.

[9]  Chee Woon Wang,et al.  Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer , 2013, BMC Cancer.

[10]  H. Brenner,et al.  Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer , 2013, PloS one.

[11]  Xiao-Feng Sun,et al.  Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer , 2013, Tumor Biology.

[12]  Li Li,et al.  Dampening Enthusiasm for Circulating MicroRNA in Breast Cancer , 2013, PloS one.

[13]  N. Miller,et al.  Circulating miR‐34a levels are reduced in colorectal cancer , 2012, Journal of surgical oncology.

[14]  Qinghua Xu,et al.  Plasma miR-601 and miR-760 Are Novel Biomarkers for the Early Detection of Colorectal Cancer , 2012, PloS one.

[15]  Qingyun Zhang,et al.  The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors , 2012, Journal of Cancer Research and Clinical Oncology.

[16]  R. Bast,et al.  Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients , 2012, Cancer.

[17]  Longgui Wang,et al.  Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. , 2012, Cancer epidemiology.

[18]  E. Kroh,et al.  Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies , 2011, Cancer Prevention Research.

[19]  M. Nykter,et al.  Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis , 2011, PloS one.

[20]  Tongyu Lin,et al.  Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression , 2010, Journal of gastroenterology and hepatology.

[21]  Jessica A. Weber,et al.  Export of microRNAs and microRNA-protective protein by mammalian cells , 2010, Nucleic acids research.

[22]  Zhaohui Huang,et al.  Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer , 2010, International journal of cancer.

[23]  Chronic Disease Division.  Cancer facts and figures , 2010 .

[24]  Y. Matsuki,et al.  Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells*♦ , 2010, The Journal of Biological Chemistry.

[25]  Zhenghe Wang,et al.  microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. , 2009, Cancer research.

[26]  George A. Calin,et al.  MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases , 2009, Expert opinion on biological therapy.

[27]  K. Ohuchida,et al.  MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance , 2009, Molecular Cancer Therapeutics.

[28]  E. Ng,et al.  Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.

[29]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[30]  R. Vyzula,et al.  Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.

[31]  Kazuhiko Hayashi,et al.  Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. , 2007, RNA.

[32]  G. Lutz,et al.  Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice , 2008, BMC biotechnology.

[33]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[34]  G. Ruvkun.  Clarifications on miRNA and Cancer , 2006, Science.

[35]  W. Filipowicz,et al.  Inhibition of Translational Initiation by Let-7 MicroRNA in Human Cells , 2005, Science.

[36]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G. Ruvkun,et al.  Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans , 1993, Cell.

[38]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[39]  Joon Cheol Park,et al.  Plasma components affect accuracy of circulating cancer-related microRNA quantitation. , 2012, The Journal of molecular diagnostics : JMD.

[40]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.